BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 10924145)

  • 1. On the concentrations of cyclins and cyclin-dependent kinases in extracts of cultured human cells.
    Arooz T; Yam CH; Siu WY; Lau A; Li KK; Poon RY
    Biochemistry; 2000 Aug; 39(31):9494-501. PubMed ID: 10924145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
    Gong J; Ammanamanchi S; Ko TC; Brattain MG
    Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
    Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
    Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of cyclin-dependent kinases CDC2 and CDK2 in hepatocellular carcinoma.
    Li KK; Ng IO; Fan ST; Albrecht JH; Yamashita K; Poon RY
    Liver; 2002 Jun; 22(3):259-68. PubMed ID: 12100577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cell cycle inhibitor p21CIP is phosphorylated by cyclin A-CDK2 complexes.
    Jaumot M; Estañol JM; Casanovas O; Graña X; Agell N; Bachs O
    Biochem Biophys Res Commun; 1997 Dec; 241(2):434-8. PubMed ID: 9425288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caco-2 intestinal cell differentiation is associated with G1 arrest and suppression of CDK2 and CDK4.
    Ding QM; Ko TC; Evers BM
    Am J Physiol; 1998 Nov; 275(5):C1193-200. PubMed ID: 9814966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase 3-mediated cleavage of p21WAF1/CIP1 associated with the cyclin A-cyclin-dependent kinase 2 complex is a prerequisite for apoptosis in SK-HEP-1 cells.
    Jin YH; Yoo KJ; Lee YH; Lee SK
    J Biol Chem; 2000 Sep; 275(39):30256-63. PubMed ID: 10884382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
    Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
    Orend G; Hunter T; Ruoslahti E
    Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.
    Nahum A; Hirsch K; Danilenko M; Watts CK; Prall OW; Levy J; Sharoni Y
    Oncogene; 2001 Jun; 20(26):3428-36. PubMed ID: 11423993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently.
    O'Connor PM; Ferris DK; Pagano M; Draetta G; Pines J; Hunter T; Longo DL; Kohn KW
    J Biol Chem; 1993 Apr; 268(11):8298-308. PubMed ID: 8463339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p21(Waf1/Cip1) inhibition of cyclin E/Cdk2 activity prevents endoreduplication after mitotic spindle disruption.
    Stewart ZA; Leach SD; Pietenpol JA
    Mol Cell Biol; 1999 Jan; 19(1):205-15. PubMed ID: 9858545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity.
    Guadagno TM; Newport JW
    Cell; 1996 Jan; 84(1):73-82. PubMed ID: 8548828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1).
    Hengst L; Göpfert U; Lashuel HA; Reed SI
    Genes Dev; 1998 Dec; 12(24):3882-8. PubMed ID: 9869641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperoxia induces S-phase cell-cycle arrest and p21(Cip1/Waf1)-independent Cdk2 inhibition in human carcinoma T47D-H3 cells.
    Bilodeau JF; Faure R; Piedboeuf B; Mirault ME
    Exp Cell Res; 2000 May; 256(2):347-57. PubMed ID: 10772807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the in vitro reconstituted cyclin A or B1-dependent cdk2 and cdc2 kinase activities.
    Pan ZQ; Amin A; Hurwitz J
    J Biol Chem; 1993 Sep; 268(27):20443-51. PubMed ID: 8397207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doenjang hexane fraction-induced G1 arrest is associated with the inhibition of pRB phosphorylation and induction of Cdk inhibitor p21 in human breast carcinoma MCF-7 cells.
    Choi YH; Choi BT; Lee WH; Rhee SH; Park KY
    Oncol Rep; 2001; 8(5):1091-6. PubMed ID: 11496322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle.
    Bresnahan WA; Boldogh I; Ma T; Albrecht T; Thompson EA
    Cell Growth Differ; 1996 Oct; 7(10):1283-90. PubMed ID: 8891332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.
    Fotedar R; Fitzgerald P; Rousselle T; Cannella D; Dorée M; Messier H; Fotedar A
    Oncogene; 1996 May; 12(10):2155-64. PubMed ID: 8668341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.